Cargando…

Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma

Melanoma is often caused by mutations due to exposure to ultraviolet radiation. This study reports a recurrent somatic C > T change causing a P131L mutation in the RQCD1 (Required for Cell Differentiation1 Homolog) gene identified through whole exome sequencing of 20 metastatic melanomas. Screeni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Stephen Q., Behren, Andreas, Mar, Victoria J., Woods, Katherine, Li, Jason, Martin, Claire, Sheppard, Karen E., Wolfe, Rory, Kelly, John, Cebon, Jonathan, Dobrovic, Alexander, McArthur, Grant A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359221/ https://www.ncbi.nlm.nih.gov/pubmed/25544760

Ejemplares similares

Tumour mutation status and sites of metastasis in patients with cutaneous melanoma
por: Adler, Nikki R, et al.
Publicado: (2017)

Obesity and the Impact on Cutaneous Melanoma: Friend or Foe?
por: Smith, Lorey K., et al.
Publicado: (2020)

Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations
por: Chang-Hao Tsao, Simon, et al.
Publicado: (2015)

Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors
por: Anaka, Matthew, et al.
Publicado: (2013)

Clustered somatic mutations are frequent in transcription factor binding motifs within proximal promoter regions in melanoma and other cutaneous malignancies
por: Colebatch, Andrew J., et al.
Publicado: (2016)

Bioinformatics Pipelines for Targeted Resequencing and Whole-Exome Sequencing of Human and Mouse Genomes: A Virtual Appliance Approach for Instant Deployment
por: Li, Jason, et al.
Publicado: (2014)

Tumour mutation status and melanoma recurrence following a negative sentinel lymph node biopsy
por: Adler, Nikki R., et al.
Publicado: (2018)

Ropporin-1 and 1B Are Widely Expressed in Human Melanoma and Evoke Strong Humoral Immune Responses
por: Da Gama Duarte, Jessica, et al.
Publicado: (2021)

Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma
por: Woods, Katherine, et al.
Publicado: (2016)

Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy
por: Prithviraj, Prashanth, et al.
Publicado: (2015)

Using whole-exome sequencing and protein interaction networks to prioritize candidate genes for germline cutaneous melanoma susceptibility
por: Yepes, Sally, et al.
Publicado: (2020)

Family-based whole-exome sequencing identifies rare variants potentially related to cutaneous melanoma predisposition in Brazilian melanoma-prone families
por: Fidalgo, Felipe, et al.
Publicado: (2022)

Identifying and targeting determinants of melanoma cellular invasion
por: Jayachandran, Aparna, et al.
Publicado: (2016)

Harnessing the immunotherapeutic potential of CDK4/6 inhibitors in melanoma: is timing everything?
por: Lelliott, Emily J., et al.
Publicado: (2022)

Metabolic Plasticity in Melanoma Progression and Response to Oncogene Targeted Therapies
por: Alkaraki, Arwa, et al.
Publicado: (2021)

Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours
por: Wong, Stephen Q., et al.
Publicado: (2013)

Systems analysis identifies miR-29b regulation of invasiveness in melanoma
por: Andrews, Miles C., et al.
Publicado: (2016)

PDCD1 Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma
por: Parakh, Sagun, et al.
Publicado: (2021)

The therapeutic potential of targeting minimal residual disease in melanoma
por: Patel, Riyaben P, et al.
Publicado: (2023)

Whole-exome sequencing identifies mutations in MYMK in a mild form of Carey-Fineman-Ziter syndrome
por: Alrohaif, Hadil, et al.
Publicado: (2018)

Novel combination therapies for BRAF-mutant melanoma
por: McArthur, Grant A
Publicado: (2015)

Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma
por: Halse, H., et al.
Publicado: (2018)

Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma
por: Sun, Wei, et al.
Publicado: (2023)

Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion
por: Prithviraj, Prashanth, et al.
Publicado: (2015)

Immunomodulatory Effects of BRAF, MEK, and CDK4/6 Inhibitors: Implications for Combining Targeted Therapy and Immune Checkpoint Blockade for the Treatment of Melanoma
por: Lelliott, Emily J., et al.
Publicado: (2021)

Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Bacillus Calmette–Guérin followed by Ipilimumab in Patients with Advanced Metastatic Melanoma
por: Da Gama Duarte, Jessica, et al.
Publicado: (2018)

Comprehensive Genomic Characterization of Cutaneous Malignant Melanoma Cell Lines Derived from Metastatic Lesions by Whole-Exome Sequencing and SNP Array Profiling
por: Cifola, Ingrid, et al.
Publicado: (2013)

Tracking extracellular vesicle phenotypic changes enables treatment monitoring in melanoma
por: Wang, Jing, et al.
Publicado: (2020)

Analysis of the Whole-Exome Sequencing of Tumor and Circulating Tumor DNA in Metastatic Melanoma
por: Diefenbach, Russell J., et al.
Publicado: (2019)

A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanoma
por: Richter, Anna, et al.
Publicado: (2013)

Capture and On-chip analysis of Melanoma Cells Using Tunable Surface Shear forces
por: Tsao, Simon Chang-Hao, et al.
Publicado: (2016)

Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT
por: Handolias, D, et al.
Publicado: (2010)

Combination Therapies to Inhibit the RAF/MEK/ERK Pathway in Melanoma: We are not Done Yet
por: McArthur, Grant A.
Publicado: (2015)

Cutaneous melanoma in women()
por: Roh, Mi Ryung, et al.
Publicado: (2015)

Cutaneous melanoma in women()()
por: Roh, Mi Ryung, et al.
Publicado: (2017)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

Effects of Epithelial to Mesenchymal Transition on T Cell Targeting of Melanoma Cells
por: Woods, Katherine, et al.
Publicado: (2014)

BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival
por: Lee, Erinna F., et al.
Publicado: (2019)

Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells
por: Jayachandran, Aparna, et al.
Publicado: (2016)

Accumulation of CD103(+) CD8(+) T cells in a cutaneous melanoma micrometastasis
por: Hochheiser, Katharina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kokj0vpcn3j7i98djc6kgkt5ul